Abstract

Prognostic factors for overall survival (OS), percutaneous endoscopic gastrostomy (PEG) dependency, and long-term speech rehabilitation via voice prosthesis (VP) after laryngectomy for laryngeal or hypopharyngeal cancer were investigated in a retrospective population-based study in Thuringia, Germany. A total of 617 patients (68.7% larynx; hypopharynx; 31.3%; 93.7% men; median age 62 years; 66.0% stage IV) from 2001 to 2020 were included. Kaplan–Meier and Cox multivariable regression analyses were performed. 23.7% of patients received a PEG. 74.7% received a VP. Median OS was 131 months. Independent factors for lower OS were stage IV (compared to stage II; hazard ratio [HR] = 3.455; confidence interval [CI] 1.395–8.556) and laryngectomy for a recurrent disease (HR = 1.550; CI 1.078–2.228). Median time to PEG removal was 7 months. Prior partial surgery before laryngectomy showed a tendency for independent association for later PEG removal (HR = 1.959; CI 0.921–4.167). Postoperative aspiration needing treatment was an independent risk factor (HR = 2.679; CI 1.001–7.167) for later definitive VP removal. Laryngectomy continuously plays an important role in a curative daily routine treatment setting of advanced laryngeal or hypopharyngeal cancer in Germany. Long-term dependency on nutrition via PEG is an important issue, whereas use of VP is a stable long-term measure for voice rehabilitation.

Details

Title
Oncological and functional outcome after laryngectomy for laryngeal and hypopharyngeal cancer: a population-based analysis in Germany from 2001 to 2020
Author
Kouka, Mussab 1 ; Beckmann, Louise 1 ; Bitter, Thomas 1 ; Kaftan, Holger 2 ; Böger, Daniel 3 ; Büntzel, Jens 4 ; Müller, Andreas 5 ; Hoffmann, Kerstin 6 ; Podzimek, Jiri 7 ; Pietschmann, Klaus 8 ; Ernst, Thomas 9 ; Guntinas-Lichius, Orlando 1   VIAFID ORCID Logo 

 Jena University Hospital, Department of Otorhinolaryngology, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224) 
 Helios-Klinikum Erfurt, Department of Otorhinolaryngology, Erfurt, Germany (GRID:grid.491867.5) (ISNI:0000 0000 9463 8339) 
 SRH Zentralklinikum Suhl, Department of Otorhinolaryngology, Suhl, Germany (GRID:grid.491867.5) 
 Suedharzklinikum Nordhausen, Department of Otorhinolaryngology, Nordhausen, Germany (GRID:grid.491867.5) 
 SRH Wald-Klinikum Gera, Department of Otorhinolaryngology, Gera, Germany (GRID:grid.492124.8) (ISNI:0000 0001 0214 7565) 
 Sophien-Hufeland-Klinikum, Department of Otorhinolaryngology, Weimar, Germany (GRID:grid.459962.5) (ISNI:0000 0004 0482 8905) 
 Klinikum Bad Salzungen, Department of Otorhinolaryngology, Bad Salzungen, Germany (GRID:grid.459962.5) 
 Jena University Hospital, Department of Radiation Oncology, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224) 
 Jena University Hospital, University Tumor Center, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224) 
Pages
7761
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3030939993
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.